Andy Fillmore, Member of Parliament for Halifax, on behalf of the Atlantic Canada Opportunities Agency (ACOA) announced a $2 million investment for a NSHA orthopaedic project on Wednesday April 17th.
Dr. Michael Dunbar and the orthopaedic research team, in conjunction with partners Kinduct, Emovi and OrthoMX, are seeking to advance the standard of care, increase treatment options and improve orthopaedic wait times.
NSHA puts a priority on translating research into clinical practice and this project will provide medical staff with enhanced information such that they can make more timely and precise decisions.
“Once again, we are drawing a straight line from research and innovation to improved patient outcomes. Nova Scotia Health Authority places a high priority on research and this particular project will advance the standard for patients who need orthopaedic care. We are very pleased to collaborate with industry partners to improve care for Nova Scotians.”
- Janet Knox, President and CEO, Nova Scotia Health Authority
The technology involved is a three part partnership between Kinduct, Emovi and OrthoMX. Kinduct developed a platform for remote patient monitoring where patients can access information about their care and interact with their healthcare team. Emovi's KneeKG system is a wearable knee assessment device that assesses knee joint functions dynamically. OrthoMX uses the InStride app to track walking patterns. These three parts together will shape the new Mobility Assessment Clinic at the QEII Health Sciences Centre.
“Today we see that meaningful collaboration fosters innovation. With the support of ACOA, our NSHA collaborative research partnership with Kinduct, Emovi and OrthoMX is bringing transformative innovations to patients across Nova Scotia.”
- Dr. Michael Dunbar, Orthopaedic Surgeon, Endowed Chair of Arthroplasty Outcomes, Queen Elizabeth II Health Sciences Centre
Congratulations to Dr. Dunbar and the orthopaedic team!
Research In Progress is the online news hub for researchers & staff at NSHA
Showing posts with label NSHA. Show all posts
Showing posts with label NSHA. Show all posts
Wednesday, April 24, 2019
Wednesday, March 13, 2019
Researchers point to diet and lifestyle as a way we can avoid premature death and disability in Canada
![]() |
| Samiah Alam & Dr. Leah Cahill |
Nutrition researchers Dr. Leah Cahill(1) and Samiah Alam set out to quantify the determinants of healthy life expectancy in Canada from the Global Burden of Diseases, Injuries and Risk Factors Study (GBD). The GBD study is "an international scientific effort to systematically quantify the comparative magnitude of global health loss resulting from disease, injuries and risk factors to inform evidence-based policy-making." While burden estimates have been presented for individual countries such as the United States, Germany and the UK to help with national policies and prioritizing, Canada had not yet been summarized.
The top 3 risk factors identified in Canada from the study were (1) tobacco, (2) diet and (3) high body mass index, followed by (4) high fasting plasma glucose, (5) high systolic blood pressure, (6) alcohol and drug use, (7) occupational risks, (8) high total cholesterol, (9) impaired kidney function and (10) air pollution. Cahill hopes the study will inform national health policy by prioritizing these risk factors in Canada. "An understanding of Canada’s foremost health problems, their risk factors, and how both are changing over time is crucial to inform national health policy and programs, health authority planning and scientific research priorities...actionable preventive strategies can lead to improved health outcomes."
Cahill used three well-established metrics to summarize health loss including
disability-adjusted life years (DALYs), total deaths and years lived with disability . "One DALY is equivalent to 1 year of healthy life (free of disease, injury or disability) lost. Because DALYs quantify both mortality and morbidity, total DALYs are considered to represent the burden of diseases and injuries for a country, indicating the gap between the country’s current health status and an ideal health situation in which the country’s entire population lives to an advanced age, free of disease and disability."
The trend for Canada from 1990 to 2016 hasn't changed at the top. Tobacco exposure has continued to be the leading risk factor followed by diet, but high BMI and high fasting plasma glucose have both increased, beating out high blood pressure and high cholesterol both of which dropped in rankings over time.
The good news is that factors proving to be the highest risk, tobacco and diet, are modifiable- change your ways, lower your own risks and reduce Canada's health burden.
1- Leah Cahill, PhD, Affiliated Scientist, QEII Health Sciences Centre, Nova Scotia Health Authority, Howard Webster Department of Medicine Research Chair and Assistant Professor, Dalhousie University, Visiting Scientist, Department of Nutrition, Harvard T. H. Chan School of Public Health
Tuesday, February 26, 2019
Personalized treatment for bipolar disorder is now an international effort
![]() |
| Dr. Martin Alda |
The PLOT-BD project aims to shorten the time to remission by studying genetic markers in patients and tailoring treatment on an individual basis. To date, treatments are chosen by trial-and-error taking months or years to become effective. This new approach being studied in Canada, France, Germany and Italy, will look to derive a set of variables associated with treatment outcome and lead to faster recovery.
| The proposed solution means shorter times to remission. |
The ERAPerMed Cofund has 32 partners from 23 countries and was cofounded by the European Commission in 2018. The PLOT-BD project was announced as one of the first projects to be funded and had to demonstrate the value of interdisciplinary study and transnational collaboration.
Welcome Dawn Munroe!
![]() |
| Dawn Munroe |
Welcome to our new HR Lead, Research- Dawn Munroe!
Dawn joined Research in January 2019 after Judi Thompson’s retirement. Dawn comes to Research after joining NSHA in 2017 following 10 + years in the non-profit sector as a Director of HR.
As HR Lead, Research, Dawn assists in recruitment, screening & selection of new employees, facilitates performance management, advises managers on organizational policy and legislation and provides continued support in all areas of human resources.
Dawn loves being active outdoors and enjoys meeting new people. If you haven’t yet, stop by her office and say hi!
Labels:
new staff,
nova scotia,
NSHA,
welcome,
women
Monday, February 25, 2019
Researcher Profile: Dr. John Fisk
What is your current research project?
![]() |
| Dr. John Fisk |
I have a number of ongoing projects together with colleagues here at NSHA and at other centres across Canada. For a number of years, I have been looking at the impact of mental health conditions, including anxiety and depression, on cognitive functioning, quality of life, and chronic disease development and progression. Most of this work has examined these issues in persons with multiple sclerosis (MS) although we are examining other chronic health conditions as well. Some of these studies have included MRI measures of brain structure and function in attempts to better understand these issues. An example of an ongoing project with colleagues here is the Lupus Brain Map Study, being led by Dr. John Hanly. In this project we are using advanced neuroimaging studies being conducted at BIOTIC, to explore associations between blood-brain-barrier permeability abnormalities and the presence of cognitive deficits as well as changes in the functional connectivity of brain networks, in persons with systemic lupus erythematosus.
How
did you become interested in your research topic?
The research that I have done
has always been informed by the people who I meet in my clinical practice,
including both my patients and my colleagues. My patients are the ones who tell
me the really important issues that need to be addressed and my colleagues
often pose the clinical conundrums that need to be understood better. What has
typically guided my research has been the fact that common themes arise across
a variety of clinical health conditions, diagnoses, and areas of clinical
practice and I enjoy the taking what I have learned in one setting and applying
that knowledge in a new setting.
What
has been unexpected about your findings so far?
To me, one of the unexpected
findings has been just how hard it is to demonstrate, through our research, some
of the things that our patients tell us regularly when we talk to them. For
example, patients with MS have often told me how their cognitive difficulties,
anxiety, depression and fatigue (for example) can be as disabling as their
neurologic symptoms. But it took a study of over 900 patients done across three
provinces, with numerous clinical and symptom measures, in order for us to
demonstrate this. We have also shown that mental health conditions can be
associated with progression of neurologic disability in MS and can precede MS
development in some. For most of the patient populations that I work with there
are common inter-related issues and understanding their relative contributions
to each individual is key.
What’s
innovative about your research?
One of the innovative aspects of
the research that I have done has been the linkage of detailed clinical data
with health administrative data at a Provincial level, and the collaboration
with others across Canada using similar linked datasets. This approach has
allowed my colleagues and me to examine associations between particular health
conditions and the development and progression of MS, and is an
approach that can be applied to other diseases as well. In doing this we have
gained opportunities to identify key factors to improve disease management as
well as suggestions of possible shared pathophysiological mechanisms that
support other areas of future research.
One
word that best describes how you work: Collaboratively
What
technology can’t you live without?
As a clinical neuropsychologist,
my work is fundamentally based on the observation and description of human
behaviour. There are many technologies that can facilitate this work, even to
the point of using MRI to examine relations between brain structure/function
and behaviour. However, since I started in this business quite a while ago,
there are really no particular technologies that I truly can’t live without to
do my work. That being said, almost all of my research involves
collaboration with colleagues who are spread out across Canada and occasionally
other countries as well. Email and internet access means that I can work as
closely with these colleagues as with my colleagues next door. Without this,
all of our work would be greatly diminished.
Subscribe to:
Posts (Atom)




